Biofortuna Ltd:企業の製品パイプライン分析2018

【英語タイトル】Biofortuna Ltd - Product Pipeline Analysis, 2018 Update

GlobalDataが出版した調査資料(DATA904C12195)・商品コード:DATA904C12195
・発行会社(調査会社):GlobalData
・発行日:2018年12月
・ページ数:33
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥222,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥333,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Biofortuna Ltd (Biofortuna) is a provider of contract services and molecular diagnostic products. The company distributes CE-marked and freeze-dried PCR diagnostic kits. It has freeze dried molecular diagnostic products targeted at the transplantation, disease identification and pharmacogenetic markets. Biofortuna offers contract development and manufacturing services. The company also offers contract IVD development and production services to companies for converting their liquid tests into freeze dried kits and delivering simple one protocols. It operates contract manufacturing facilities in the UK. Biofortuna is headquartered in Bromborough, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Biofortuna Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Biofortuna Ltd Company Overview 5
Biofortuna Ltd Company Snapshot 5
Biofortuna Ltd Pipeline Products and Ongoing Clinical Trials Overview 5
Biofortuna Ltd – Pipeline Analysis Overview 7
Biofortuna Ltd – Key Facts 7
Biofortuna Ltd – Major Products and Services 8
Biofortuna Ltd Pipeline Products by Development Stage 9
Biofortuna Ltd Pipeline Products Overview 11
CoaguPlex Genotyping Kit 11
CoaguPlex Genotyping Kit Product Overview 11
HemoPlex Kell Genotyping Kit 12
HemoPlex Kell Genotyping Kit Product Overview 12
HemoPlex Kidd & Duffy Genotyping Kit 13
HemoPlex Kidd & Duffy Genotyping Kit Product Overview 13
HemoPlex MNS Genotyping Kit 14
HemoPlex MNS Genotyping Kit Product Overview 14
HemoPlex Multi Blood Group Genotyping Kit 15
HemoPlex Multi Blood Group Genotyping Kit Product Overview 15
HemoPlex RHCE Screening Kit 16
HemoPlex RHCE Screening Kit Product Overview 16
HemoPlex RHCE Variant Genotyping Kit 17
HemoPlex RHCE Variant Genotyping Kit Product Overview 17
HemoPlex RHD & CE Genotyping Kit 18
HemoPlex RHD & CE Genotyping Kit Product Overview 18
HemoPlex RHD Screening Kit 19
HemoPlex RHD Screening Kit Product Overview 19
HemoPlex RHD Variant Genotyping Kit 20
HemoPlex RHD Variant Genotyping Kit Product Overview 20
NeutroPlex HNA Genotyping Kit 21
NeutroPlex HNA Genotyping Kit Product Overview 21
ThromboPlex HPA Genotyping Kit 22
ThromboPlex HPA Genotyping Kit Product Overview 22
ThromboPlex HPA Screening Kit 23
ThromboPlex HPA Screening Kit Product Overview 23
Biofortuna Ltd – Key Competitors 24
Biofortuna Ltd – Key Employees 25
Biofortuna Ltd – Locations And Subsidiaries 26
Head Office 26
Recent Developments 27
Biofortuna Ltd, Recent Developments 27
Jan 24, 2017: Biofortuna expands its immunoassay development and manufacturing services 27
Oct 03, 2016: Biofortuna Reaches key Milestones for ReadyPlex Blood Group Genotyping product Family 27
Jul 08, 2016: Biofortuna FDA Inspection Completed Successfully 27
Jul 27, 2015: Biofortuna launches its new approach to custom IVD manufacture and development services 28
Feb 24, 2015: Biofortuna appoints new Chairman to lead next phase of growth 28
Aug 08, 2014: Biofortuna expands its infrastructure and production capacity 28
Feb 25, 2014: Biofortuna receives FDA clearance of its SSPGo line of HLA molecular diagnostic freeze-dried kits 29
Mar 18, 2013: Biofortuna announces significant expansion of its infrastructure and head count 29
Appendix 30
Methodology 30
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Biofortuna Ltd Pipeline Products and Ongoing Clinical Trials Overview 5
Biofortuna Ltd Pipeline Products by Equipment Type 6
Biofortuna Ltd Pipeline Products by Indication 6
Biofortuna Ltd, Key Facts 7
Biofortuna Ltd, Major Products and Services 8
Biofortuna Ltd Number of Pipeline Products by Development Stage 9
Biofortuna Ltd Pipeline Products Summary by Development Stage 10
CoaguPlex Genotyping Kit - Product Status 11
CoaguPlex Genotyping Kit - Product Description 11
HemoPlex Kell Genotyping Kit - Product Status 12
HemoPlex Kell Genotyping Kit - Product Description 12
HemoPlex Kidd & Duffy Genotyping Kit - Product Status 13
HemoPlex Kidd & Duffy Genotyping Kit - Product Description 13
HemoPlex MNS Genotyping Kit - Product Status 14
HemoPlex MNS Genotyping Kit - Product Description 14
HemoPlex Multi Blood Group Genotyping Kit - Product Status 15
HemoPlex Multi Blood Group Genotyping Kit - Product Description 15
HemoPlex RHCE Screening Kit - Product Status 16
HemoPlex RHCE Screening Kit - Product Description 16
HemoPlex RHCE Variant Genotyping Kit - Product Status 17
HemoPlex RHCE Variant Genotyping Kit - Product Description 17
HemoPlex RHD & CE Genotyping Kit - Product Status 18
HemoPlex RHD & CE Genotyping Kit - Product Description 18
HemoPlex RHD Screening Kit - Product Status 19
HemoPlex RHD Screening Kit - Product Description 19
HemoPlex RHD Variant Genotyping Kit - Product Status 20
HemoPlex RHD Variant Genotyping Kit - Product Description 20
NeutroPlex HNA Genotyping Kit - Product Status 21
NeutroPlex HNA Genotyping Kit - Product Description 21
ThromboPlex HPA Genotyping Kit - Product Status 22
ThromboPlex HPA Genotyping Kit - Product Description 22
ThromboPlex HPA Screening Kit - Product Status 23
ThromboPlex HPA Screening Kit - Product Description 23
Biofortuna Ltd, Key Employees 25
Glossary 32

List of Figures
Biofortuna Ltd Pipeline Products by Equipment Type 6
Biofortuna Ltd Pipeline Products by Development Stage 9

★調査レポート[Biofortuna Ltd:企業の製品パイプライン分析2018] (コード:DATA904C12195)販売に関する免責事項を必ずご確認ください。
★調査レポート[Biofortuna Ltd:企業の製品パイプライン分析2018]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆